Tickborne Meningoencephalitis, First Case after 19 Years in Northeastern Germany by Hemmer, Christoph J. et al.
LETTERS
Tickborne Meningo-
encephalitis, First
Case after 19 Years
in Northeastern
Germany 
To the Editor: Tickborne enceph-
alitis virus (TBEV) is focally distrib-
uted in Europe and Asia (between 42°
and 63° north latitude). Recently, 5
human tickborne encephalitis cases
have been reported, and anti-tick-
borne encephalitis antibody preva-
lence in dogs has been observed in
southern Norway (1). In the last 2
decades, mild winters may have
favored a northbound spread and
increased tickborne encephalitis inci-
dence (2). Tickborne encephalitis is
endemic in southern Germany, but no
cases had been reported in northeast
Germany since 1985 (3,4). 
A 61-year-old man was bitten by a
tick at Lake Woblitz, near the town of
Neustrelitz in former East Germany,
on May 31, 2004, between 8:00 a.m.
and 4:00 p.m. The patient’s history
showed no other tick bites, no stays in
tickborne encephalitis–endemic areas,
and no tickborne encephalitis vacci-
nation. 
On June 9, transient fever and
headache developed in the patient,
followed 6 days later by difficulty in
concentrating, apathy, and a strong
urge to sleep. On June 23, the patient
was hospitalized with fever (tempera-
ture 39.2°C) and mental confusion.
Because he had cruised the Nile in
December 2003, he was transferred to
the Tropical Medicine Division of
Rostock University to exclude a diag-
nosis of malaria. Somnolence, slurred
speech, amnestic dysphasia, and
impaired fine motor control, but no
meningism, focal signs, pyramidal
tract, or sensation impairment, were
observed. Results of magnetic reso-
nance imaging brain scan and elec-
troencephalogram were normal. 
Laboratory tests showed leukocy-
tosis of 9,400 leukocytes/µL and lym-
phocytopenia of 12%. Alpha-amylase
was 254 U/L, lipase 84 U/L, sodium
131 mmol/L, and fibrinogen 4.4 g/L.
C-reactive protein and all other routine
laboratory parameters were normal.
In the serum, immunoglobulin
(Ig)G, but not IgM, was detected
against Borrelia burgdorferi. Tests of
cerebrospinal fluid (CSF) specimens,
including polymerase chain reaction
(PCR) for herpes simplex virus types
1 and 2, varicella zoster virus,
Epstein-Barr virus (EBV), cytomega-
lovirus, and human herpesvirus 6
were negative. Antibody tests for
Borrelia burgdorferi,  Mycoplasma
pneumoniae, Bartonella,  Brucella,
Leptospira interrogans, HIV, EBV,
and arboviruses were negative. VDRL
(Venereal Disease Research Labor-
atory) tests, Gram stains, and routine
bacterial cultures for common
pathogens were also negative (5).
Tests on CSF showed mild pleocy-
tosis (9 leukocytes/µL) and high pro-
tein concentration (1,322 g/L). Most
cells were lymphocytes (89%) and
monocytes (10%). Protein analysis
showed blood-brain barrier impair-
ment and intrathecal IgM synthesis. 
Anti-tickborne encephalitis virus
IgG and IgM antibodies were
detectable in the serum by enzyme-
linked immunosorbent assay 29 days
after the tick bite; corresponding CSF
titers were borderline. One week later,
IgG and IgM antibodies were positive
in serum and CSF, while CSF leuko-
cyte count and protein concentration
were normal. The anti-tickborne
encephalitis serum immunofluores-
cence titer rose from 1:80 (June 29) to
1:640 (July 14); titers against dengue,
West Nile, yellow fever, and Japan B
encephalitis were not elevated. Even
though CSF specimens were negative
for TBEV genome on 2 occasions, a
confirmed tickborne encephalitis case
had to be reported to the health
authorities. 
With symptomatic therapy, the
patient’s condition improved, and he
was discharged on July 7 with slight
mental slowing. By July 14, he had
recovered completely. 
Our patient had acquired tickborne
encephalitis at a popular tourist site
(Figure), where no human cases had
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Figure. European tickborne encephalitis–endemic areas (shaded areas) and new infection
site of case in northeastern Germany (arrow). Map provided by Baxter Germany GmbH.LETTERS
occurred for 19 years. From 1959 to
1983, numerous TBEV foci existed in
northeastern Germany (3). From 1960
to 1985, a total of 4 human cases were
seen 10 km east of Neustrelitz. From
1983 to 1989, numerous attempts to
cultivate TBEV from ticks or small
mammals failed (3). In 1992, TBEV
genome was detected by PCR in 3 tick
pools from the island of Usedom, and
in 2 pools from the Darss peninsula,
100 km northeast of Neustrelitz. From
1993 to July 2004, TBEV genome
was not detected in 16,098 ticks col-
lected from 275 regions of northeast-
ern Germany, including the county
where Lake Woblitz is situated, as
part of a statewide surveillance pro-
gram (State Health Services, unpub.
data). However, during 2004, this
county reported 24 cases of Lyme dis-
ease (2003: 10 cases; 2002: 8 cases;
2001: 1 case). Therefore, our tick-
borne encephalitis case might repre-
sent intensified amplification cycles
of tickborne infectious agents in 2004. 
The absence of tickborne
encephalitis cases for 20 years does
not likely represent a lack of data
before or a lack of interest after the
reunification of Germany. Tickborne
encephalitis was a reportable disease
under East German regulations, and
tickborne encephalitis surveillance
was intensified after reunification (3). 
Eight weeks after our patient’s tick
bite, 160 Ixodes ricinus ticks were
collected from 10 pools near Lake
Woblitz. RNAwas isolated in 5 mol/L
guanidium isothiocyanate solution,
extracted by phenolchloroform, and
precipitated with ethanol. cDNA was
amplified by nested reverse transcrip-
tion–PCR and detected by elec-
trophoresis (6). In 2 of these pools,
PCR directed towards the 5′ terminal
noncoding region of the TBEV
genome yielded a 104-bp fragment,
but the sequence was not specific for
flaviviruses. 
This case does not prove a north-
bound spread of tickborne encephali-
tis in northeastern Germany. Rather, it
shows that after years of negative
tickborne encephalitis test results in
ticks, old tickborne encephalitis foci
may retain activity. Thus, tickborne
encephalitis should be included in the
differential diagnosis of meningoen-
cephalitis in northeastern Germany,
even if the patient has not been in
tickborne encephalitis–endemic areas.
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Social Impact of
Leishmaniasis,
Afghanistan
To the Editor: For almost a
decade, Kabul, Afghanistan, has had
the highest incidence of cutaneous
leishmaniasis in the world, with an
estimated 67,500 to 200,000 cases
each year (1–3). Because of sandfly
vector exposure, most leishmaniasis
lesions occur on the face; anecdotal
reports of severe stigma are associat-
ed with the disease (3). To prioritize
aspects of operational activities and
before developing a disease-specific
health education strategy, we collect-
ed data on knowledge, attitudes, and
perceptions regarding leishmaniasis.
In October 2002, we randomly
chose 5 of Kabul’s 14 administrative
districts to carry out a house-to-house
survey (HHS) as well as 13 focus
group discussions (FGDs) with
women. The 5 districts chosen were
Karti-Seh (HHS) and Dasht-e-Barchi
(4 FGDs), Karti-Now (3 FGDs),
Arzam Qemat (3 FGDs), and Rahman
Mena (3 FGDs). The survey was con-
ducted by using a standardized, multi-
ple-choice questionnaire. The most
senior, available family member in
252 neighboring households was
interviewed, after the first household
was randomly selected (2). We
focused on women in FGDs because
they have greater risk for leishmania-
sis than men (2,3) and are often the
primary caregivers in Afghan culture
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